Secondary polycythaemia

D3_SCNDPOLYCYTHAEMIA

polycythemia: Abnormally high mass or concentration of red blood cells in the blood, either due to an increase in erythropoiesis or a decrease in plasma volume.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 D75.1
Hospital discharge: ICD-9 2890
Hospital discharge: ICD-8 28900
Cause of death: ICD-10 D75.1
Cause of death: ICD-9 2890
Cause of death: ICD-8 28900

417

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

417

diagram downward connector

Check minimum number of events None

417

diagram downward connector

Include endpoints None

417

diagram downward connector
D3_SCNDPOLYCYTHAEMIA

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D75
Name in latin Polycythaemia secundaria

Similar endpoints

List of similar endpoints to Secondary polycythaemia based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 407 141 266
Unadjusted prevalence (%) 0.13 0.08 0.20
Mean age at first event (years) 55.89 54.98 56.37

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: D3_SCNDPOLYCYTHAEMIA – Secondary polycythaemia
GWS hits: 2

Survival analyses between endpoints

Plot

before Secondary polycythaemia
after Secondary polycythaemia

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Secondary polycythaemia